Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical investor presentation detailing its portfolio of fluid overload treatment solutions for liver disease, heart failure, and cancer. The presentation covers the alfapump® system, which is under clinical investigation via the POSEIDON Study, and DSR® therapy in pre-clinical and clinical development.
conference
21 Pages
investor_presentation
28 Pages
Nautilus
Virpax Pharmaceuticals VRPX 2024 Investor Presentation
investor_presentationinvestor_presentation
29 Pages
Virpax Pharmaceuticals, Inc.